Here’s a look at the most recent, promising research on psychedelics and mental health.
Read moreStudy Shows People Who Use Psychedelics Were Under Less Stress During Covid-19 Lockdowns
“Authors write that there are several things to consider before assuming psychedelics are entirely responsible for lower stress levels during lockdown, including better mental health measures among users, like more time spent outdoors, and healthy habits, such as a good diet and less time watching Covid-related news.”
Read moreMicrodosing Research
This study looks at four scientific articles on microdosing. Three of these indicate potential benefits from microdosing.
Read moreThe Masks We Wear
The disguises we wear every day… Hiding your feelings can be freeing. But eventually you have to take off the mask.
Read moreBBC Future profile on Psychedelics
By highlighting the rapid increase in psychedelic research over the past ten years, Ed Prideaux of BBC explains how clinical trial results, favorable media coverage, and the potential development of new mental health treatments are steadily moving the public perception of psychedelics toward mainstream acceptance.
"Now the efforts of Doblin and others are finally paying off,” writes Prideaux. "Promising clinical trials suggest that psychedelics may prove game-changing treatments for depression, PTSD and addiction."
Read morePsychedelics Going Mainstream
The growing legitimacy of psychedelics as therapies promises to transform how we view the extraordinary.
Read morePsilocybin Latest Research
Yale scientists have found that a single dose of psilocybin given to mice induces a rapid and long-lasting increase in connections between pyramidal neurons in the medial frontal cortex, an area of the brain known to be involved in control and decision-making.
Read moreLatest Research on Microdosing
The jury is out on the effectiveness of microdosing psychedelics, experts say.
But definitely don't do it at work.
Read moreLatest Research on Psychedelics and Depression
Here’s the latest on how there is a shift in psychiatry toward a new way of thinking about depression, its causes, and therapies.
The profession’s long embrace of the “monoamine hypothesis” — the idea that depression primarily results from abnormal levels of neurotransmitter chemicals in the brain and that drugs can restore the proper balance — is giving way to a more complex understanding and alternative treatments, from ketamine to psychedelics to magnetic stimulation.
Read moreFantastic Fungi on Netflix
The film Fantastic Fungi is now available on Netflix… check it out!
Read morePsychedelics As Medicine
Psychedelics are promising treatments for mental illness. Dozens of new startups have sprung up to develop and deliver the drugs to patients in need.
Read more